Work

P1-132: Phase II study of erlotinib plus bevacizumab in patients with previously treated malignant pleural mesothelioma

Year: 2007

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/01.jto.0000283746.77974.fc

Authors: David M. Jackman, Hedy L. Kindler, Panagiotis Fidias, Ravi Salgia, Joan Lucca, Patricia Ostler, Linda K. Morse, Thomas J. Lynch, Bruce E. Johnson, Pasi A. Janne

Institutions: Dana-Farber Cancer Institute, University of Chicago, Massachusetts General Hospital

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2520722591

FWCI:

Cites:

Cited by:

Related to: 10